Modified CapeOX regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Modified CapeOX regimen, covering 2024-06-05 to 2024-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer [Phase 2, Phase 3]